MTVA
MTVA
NASDAQ · Biotechnology

Metavia Inc

$1.17
-0.05 (-4.10%)
Financial Highlights (FY 2025)
Revenue
913.8K
Net Income
-134,164
Gross Margin
56.7%
Profit Margin
-14.7%
Rev Growth
+16.4%
D/E Ratio
1.08
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 56.7% 56.7% 56.7%
Operating Margin -15.6% -15.1% -17.6%
Profit Margin -14.7% -18.2% -16.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 913.8K 821.5K 988.8K
Gross Profit 518.3K 465.9K 560.8K
Operating Income -142,591 -123,749 -173,954
Net Income -134,164 -149,522 -162,197
Gross Margin 56.7% 56.7% 56.7%
Operating Margin -15.6% -15.1% -17.6%
Profit Margin -14.7% -18.2% -16.4%
Rev Growth +16.4% +11.0% +21.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.84M 2.52M 2.63M
Total Equity 2.63M 2.94M 3.09M
D/E Ratio 1.08 0.86 0.85
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -201,888 -178,889 -216,043
Free Cash Flow -124,461 -98,758 -111,181